120
Yazer MH, Anani WQ, Denomme GA, Karafin MS, Sayers M, Shaz BH on behalf of the Biomedical Excellence for Safer Transfusion (BEST) Collaborative.
Trends in antigen-negative red blood cell distributions by racial or ethnic groups in the United States.
Transfusion 2018; 58: 145–150.
119
Seheult JN, Shaz B, Bravo M, Croxon H, Devine D, Doncaster C, Field S, Flanagan P, Germain M, Gregoire Y, Karafin M, Kelting N, Lewis M, O’Brien C, Murphy MF, Rossmann S, Sayers M, Shinar E, Takanashi M, Titelstad K, Yazer MH on behalf of the Biomedical Excellence for Safer Transfusion (BEST) Collaborative.
Changes in plasma unit distributions to hospitals over a 10 year period.
Transfusion. 2018 Apr;58(4):1012-1020.
118
Dyer C, Alquist CR, Cole-Sinclair M, Curnow E, Dunbar NM, Estcourt LJ, Kaufman R, Kutner JM, McCullough J, McQuilten Z, Potiphar L, Rioux-Masse B, Slichter S, Tinmouth A, Webert K, Yokoyama AP, Stanworth SJ; BEST Collaborative.
A multicentred study to validate a consensus bleeding assessment tool developed by the biomedical excellence for safer transfusion collaborative for use in patients with haematological malignancy.
Vox Sang. 2018 Apr;113(3):251-259.Epub 2018 Jan 10.
117
Gniadek TJ, Garritsen HSP, Stroncek D, Szczepiorkowski AM, and McKenna D,on behalf of the Biomedical Excellence for Safer Transfusion (BEST) Collaborative.
Optimal Storage Conditions for Apheresis Research (OSCAR): a Biomedical Excellence for Safer Transfusion (BEST) Collaborative study.
Transfusion. 2018 Feb;58(2):461-469.
116
Zeller MP, Barty R, Dunbar NM, Elahie A, Flanagan P, Garritsen H, Kutner JM, Pagano MB, Pogłód R, Rogers TS, Staves J, van Wordragen-Vlaswinkel M, Zwaginga JJ, Murphy MF, Heddle NM, Yazer MH, on behalf of the Biomedical Excellence for Safer Transfusion (BEST) Collaborative.
An international investigation into AB plasma administration in hospitals: how many AB plasma units were infused? The HABSWIN study.
Transfusion. 2018 Jan;58(1):151-157.
115
Goldman M, Steele WR, di Angelantonio E, van den Hurk K, Vassallo RR, Germain M, O’Brien SF.
Comparison of donor and general population demographics over time: a BEST Collaborative group study.
Transfusion 2017 Oct;57(10):2469-2476.
114
Gorlin J, Kinney S, Fung MK, Tinmouth A, for the BEST Collaborative.
Prothrombin complex concentrate for emergent reversal of warfarin: an international survey of hospital protocols.
Vox Sang. 2017 Aug;112(6):595-597. doi: 10.1111/vox.12539. Epub 2017 Jun 21.
113
Dunbar NM, Yazer MH, On behalf of the Biomedical Excellence for Safer Transfusion (BEST) Collaborative and the STAT Study Investigators.
Safety of the use of group A plasma in trauma: the STAT study.
Transfusion. 2017 Aug;57(8):1879-1884.
112
Zeller MP, Barty R, Aandahl A, Apelseth TO, Callum J, Dunbar NM, Elahie A, Garritsen H, Hancock H, Kutner JM, Manukian B, Mizuta S, Okuda M, Pagano MB, Pogłód R, Rushford K, Selleng K, Sørensen CH, Sprogøe U, Staves J, Weiland T, Wendel S, Wood EM17, van de Watering L, van Wordragen-Vlaswinkel M, Ziman A, Jan Zwaginga J, Murphy MF, Heddle NM, Yazer MH; Biomedical Excellence for Safer Transfusion (BEST) Collaborative.
An international investigation into O red blood cell unit administration in hospitals: the GRoup O Utilization Patterns (GROUP) study.
Transfusion. 2017 Oct;57(10):2329-2337.
111
Liu S, de Castro LF, Jin P, Civini S, Ren J, Reems JA, Cancelas J, Nayak R, Shaw G, O'Brien T, McKenna DH, Armant M, Silberstein L, Gee AP, Hei DJ, Hematti P, Kuznetsov SA, Robey PG, Stroncek DF.
Manufacturing Differences Affect Human Bone Marrow Stromal Cell Characteristics and Function: Comparison of Production Methods and Products from Multiple Centers.
Sci Rep. 2017 Apr 27;7:46731. doi: 10.1038/srep46731.
